Emily MacInnis

News

Sports

Arts

Opinion

The Quad

Photo

Video

Illustrations

Cartoons

Graphics

The Stack

PRIME

Enterprise

Interactives

Podcasts

Games

Classifieds

Print issues

robots

Researchers at the UCLA Jonsson Comprehensive Cancer Center may have discovered a safer immunotherapy treatment for melanoma, a skin cancer. The treatment uses NKTR-214 instead of the potentially harmful interleukin-2, which scientists hope will be more effective in treating cancer. (Daily Bruin file photo)

https://dailybruin.com/2020/02/02/new-type-of-immunotherapy-may-better-treat-melanoma-according-to-ucla-led-study/melanomapic/

twitter:card

twitter:description

twitter:title

twitter:site

https://wp.dailybruin.com/images/2020/02/melanomapic.jpg

twitter:image

twitter:creator

melanomapic - Daily Bruin

Campus

Science & Health

db-story-d2

Daily Bruin

New type of immunotherapy may better treat melanoma, according to UCLA-led study - Daily Bruin

New type of immunotherapy may better treat melanoma, according to UCLA-led study

max-snippet:-1, max-image-preview:large, max-video-preview:-1

This post was updated Feb. 3 at 10:29 a.m. A new form of immunotherapy may be effective in combating skin cancer, according to a UCLA-led study.

https://dailybruin.com/2020/02/02/new-type-of-immunotherapy-may-better-treat-melanoma-according-to-ucla-led-study/

Sunday, April 5, 2026

New type of immunotherapy may better treat melanoma, according to UCLA-led study

By Emily MacInnis

Feb. 2, 2020 11:24 p.m.